Condition: Lung Cancer · Sponsor: Creo Medical Limited
The overall purpose of this study is to characterise the clinical safety and performance of the Creo Medical MicroBlate™ Flex AB1 instrument in patients with pathologically confirmed malignancy eligible for surgical resection of their nodule, receiving bronchoscopic ablation prior to surgery.
This description comes directly from the study's public registry record.
Charlie Campion · +44 7939 600137 · Charlie.Campion@creomedical.com
Annie Goulding · +44 1291 606 005 · Annie.Goulding@creomedical.com
Always discuss trial participation with your own doctor first.
| Amsterdam University Medical Centres, Location AMC, Meibergdreef 9 | Amsterdam, The Netherlands, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06689488